We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Carcinogenic Effect of Asbestos Linked to Chronic Inflammation

By LabMedica International staff writers
Posted on 15 Jul 2010
Cancer researchers have identified the molecular basis for how a potent cytotoxic agent like asbestos is able to function as a carcinogen.

Exposure to asbestos is associated with the risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen and is resistant to current therapies. More...
Since asbestos kills human mesothelial cells (HM), it has been difficult to understand how this substance could also act to trigger mesothelioma formation.

Now, a study published in June 28, 2010, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) has presented an explanation for this paradox by linking asbestos-induced HM cell death, which is a regulated form of necrosis, to carcinogenesis.

Asbestos-exposed HM cells activate the enzyme poly(ADP-ribose) polymerase, secrete hydrogen peroxide, deplete ATP, and translocate high-mobility group box 1 protein (HMGB1) from the nucleus to the cytoplasm, and into the extracellular space. The release of HMGB1 induces macrophages to secrete TNF-alpha (tumor necrosis factor-alpha), which protects HM from asbestos-induced cell death and triggers a chronic inflammatory response. Protection from cell death in an environment of chronic inflammation favors transformation of HM into cancer cells.

This study emphasized the role of inflammation in the development of mestothelioma and suggested novel clinical tools to identify exposed individuals and prevent or decrease tumor growth. The investigators at the Cancer Research Center of Hawaii (Honolulu, USA) ponder whether it is possible to prevent mesothelioma, like colon cancer, simply by taking aspirin or similar drugs that stop inflammation. This hypothesis will be tested in future studies.

Related Links:

Cancer Research Center of Hawaii




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.